Trial Profile
Outcomes for Medicare Asthma Patients Taking Fluticasone Propionate/Salmeterol Combination Versus Inhaled Corticosteroid (ICS) or Other Combination Therapy.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary) ; Beclometasone; Budesonide; Corticosteroids; Flunisolide; Fluticasone propionate; Mometasone
- Indications Asthma
- Focus Therapeutic Use
- Sponsors GSK
- 06 May 2011 New trial record